166 related articles for article (PubMed ID: 24481410)
1. Serum carboxymethyllysine, an advanced glycation end product, and age-related macular degeneration: the Age, Gene/Environment Susceptibility-Reykjavik Study.
Semba RD; Cotch MF; Gudnason V; Eiríksdottir G; Harris TB; Sun K; Klein R; Jonasson F; Ferrucci L; Schaumberg DA
JAMA Ophthalmol; 2014 Apr; 132(4):464-70. PubMed ID: 24481410
[TBL] [Abstract][Full Text] [Related]
2. Prevalence of age-related macular degeneration in old persons: Age, Gene/environment Susceptibility Reykjavik Study.
Jonasson F; Arnarsson A; Eiríksdottir G; Harris TB; Launer LJ; Meuer SM; Klein BE; Klein R; Gudnason V; Cotch MF
Ophthalmology; 2011 May; 118(5):825-30. PubMed ID: 21126770
[TBL] [Abstract][Full Text] [Related]
3. Serum lipids in adults with late age-related macular degeneration: a case-control study.
Semba RD; Moaddel R; Cotch MF; Jonasson F; Eiriksdottir G; Harris TB; Launer LJ; Sun K; Klein R; Schaumberg DA; Jónsson P; Gudnason V; Ferrucci L
Lipids Health Dis; 2019 Jan; 18(1):7. PubMed ID: 30621701
[TBL] [Abstract][Full Text] [Related]
4. Five-year incidence, progression, and risk factors for age-related macular degeneration: the age, gene/environment susceptibility study.
Jonasson F; Fisher DE; Eiriksdottir G; Sigurdsson S; Klein R; Launer LJ; Harris T; Gudnason V; Cotch MF
Ophthalmology; 2014 Sep; 121(9):1766-72. PubMed ID: 24768241
[TBL] [Abstract][Full Text] [Related]
5. Age-related macular degeneration and mortality in community-dwelling elders: the age, gene/environment susceptibility Reykjavik study.
Fisher DE; Jonasson F; Eiriksdottir G; Sigurdsson S; Klein R; Launer LJ; Gudnason V; Cotch MF
Ophthalmology; 2015 Feb; 122(2):382-90. PubMed ID: 25264026
[TBL] [Abstract][Full Text] [Related]
6. Plasma protein pentosidine and carboxymethyllysine, biomarkers for age-related macular degeneration.
Ni J; Yuan X; Gu J; Yue X; Gu X; Nagaraj RH; Crabb JW;
Mol Cell Proteomics; 2009 Aug; 8(8):1921-33. PubMed ID: 19435712
[TBL] [Abstract][Full Text] [Related]
7. Incidence of Age-Related Macular Degeneration in a Multi-Ethnic United States Population: The Multi-Ethnic Study of Atherosclerosis.
Fisher DE; Klein BE; Wong TY; Rotter JI; Li X; Shrager S; Burke GL; Klein R; Cotch MF
Ophthalmology; 2016 Jun; 123(6):1297-308. PubMed ID: 26896123
[TBL] [Abstract][Full Text] [Related]
8. Prevalence of age-related macular degeneration in 4 racial/ethnic groups in the multi-ethnic study of atherosclerosis.
Klein R; Klein BE; Knudtson MD; Wong TY; Cotch MF; Liu K; Burke G; Saad MF; Jacobs DR
Ophthalmology; 2006 Mar; 113(3):373-80. PubMed ID: 16513455
[TBL] [Abstract][Full Text] [Related]
9. Fifteen-year cumulative incidence of age-related macular degeneration: the Beaver Dam Eye Study.
Klein R; Klein BE; Knudtson MD; Meuer SM; Swift M; Gangnon RE
Ophthalmology; 2007 Feb; 114(2):253-62. PubMed ID: 17270675
[TBL] [Abstract][Full Text] [Related]
10. Risk factors for incident age-related macular degeneration: pooled findings from 3 continents.
Tomany SC; Wang JJ; Van Leeuwen R; Klein R; Mitchell P; Vingerling JR; Klein BE; Smith W; De Jong PT
Ophthalmology; 2004 Jul; 111(7):1280-7. PubMed ID: 15234127
[TBL] [Abstract][Full Text] [Related]
11. Markers of inflammation, oxidative stress, and endothelial dysfunction and the 20-year cumulative incidence of early age-related macular degeneration: the Beaver Dam Eye Study.
Klein R; Myers CE; Cruickshanks KJ; Gangnon RE; Danforth LG; Sivakumaran TA; Iyengar SK; Tsai MY; Klein BE
JAMA Ophthalmol; 2014 Apr; 132(4):446-55. PubMed ID: 24481424
[TBL] [Abstract][Full Text] [Related]
12. The prevalence of age-related maculopathy in iceland: Reykjavik eye study.
Jonasson F; Arnarsson A; Sasaki H; Peto T; Sasaki K; Bird AC
Arch Ophthalmol; 2003 Mar; 121(3):379-85. PubMed ID: 12617709
[TBL] [Abstract][Full Text] [Related]
13. Prevalence of age-related macular degeneration in elderly Caucasians: the Tromsø Eye Study.
Erke MG; Bertelsen G; Peto T; Sjølie AK; Lindekleiv H; Njølstad I
Ophthalmology; 2012 Sep; 119(9):1737-43. PubMed ID: 22608479
[TBL] [Abstract][Full Text] [Related]
14. Vitamin D Status and Prevalent Early Age-Related Macular Degeneration in African Americans and Caucasians: The Atherosclerosis Risk in Communities (ARIC) Study.
Millen AE; Nie J; Sahli MW; Mares JA; Meyers KJ; Klein BEK; LaMonte MJ; Lutsey PL; Andrews CA; Klein R
J Nutr Health Aging; 2017; 21(7):772-780. PubMed ID: 28717807
[TBL] [Abstract][Full Text] [Related]
15. Ethnic Differences in the Association Between Age-Related Macular Degeneration and Vision-Specific Functioning.
Fenwick EK; Man REK; Cheung CMG; Sabanayagam C; Cheng CY; Neelam K; Chua J; Gan ATL; Mitchell P; Wong TY; Lamoureux EL
JAMA Ophthalmol; 2017 May; 135(5):469-476. PubMed ID: 28358956
[TBL] [Abstract][Full Text] [Related]
16. 5-year incidence of age-related maculopathy in the Reykjavik Eye Study.
Jonasson F; Arnarsson A; Peto T; Sasaki H; Sasaki K; Bird AC
Ophthalmology; 2005 Jan; 112(1):132-8. PubMed ID: 15629833
[TBL] [Abstract][Full Text] [Related]
17. Incidence and progression of reticular drusen in age-related macular degeneration: findings from an older Australian cohort.
Joachim N; Mitchell P; Rochtchina E; Tan AG; Wang JJ
Ophthalmology; 2014 Apr; 121(4):917-25. PubMed ID: 24332537
[TBL] [Abstract][Full Text] [Related]
18. Serum leptin and age-related macular degeneration.
Seshasai S; Liao J; Toh QC; Cheng CY; Cheung GC; Sethi S; Wong TY; Sabanayagam C
Invest Ophthalmol Vis Sci; 2015 Feb; 56(3):1880-6. PubMed ID: 25711634
[TBL] [Abstract][Full Text] [Related]
19. Risk factors for the incidence of Advanced Age-Related Macular Degeneration in the Age-Related Eye Disease Study (AREDS) AREDS report no. 19.
Clemons TE; Milton RC; Klein R; Seddon JM; Ferris FL;
Ophthalmology; 2005 Apr; 112(4):533-9. PubMed ID: 15808240
[TBL] [Abstract][Full Text] [Related]
20. Incidence and progression of geographic atrophy: observations from a population-based cohort.
Joachim N; Mitchell P; Kifley A; Rochtchina E; Hong T; Wang JJ
Ophthalmology; 2013 Oct; 120(10):2042-50. PubMed ID: 23706948
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]